Search research articles
Contact Us
Filters
Showing results (411-420 of 447) with videos related to
Page
of 45
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2022
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer
Jonathan H Shepherd, Karla Ballman, Mei-Yin C Polley, et al.
Cancer Cell
|
February 5, 2010
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, et al.
Cancer Discovery
|
June 18, 2016
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer
Haikuo Zhang, Jun Qi, Jaime M Reyes, et al.
Nature Communications
|
September 3, 2021
Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer
Nathan F Schachter, Jessica R Adams, Patryk Skowron, et al.
NPJ Breast Cancer
|
May 13, 2021
FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036
Steven P Angus, Timothy J Stuhlmiller, Gaurav Mehta, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 5, 2025
Integration of Gene Expression and Digital Histology to Predict Treatment-Specific Responses in Breast Cancer
Frederick M Howard, James Dolezal, Hanna Hieromnimon, et al.
Cell
|
August 12, 2014
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
Katherine A Hoadley, Christina Yau, Denise M Wolf, et al.
Breast Cancer Research and Treatment
|
December 27, 2011
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
Laura J Esserman, Donald A Berry, Maggie C U Cheang, et al.
The Lancet. Oncology
|
November 5, 2020
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation
Aleix Prat, Valentina Guarneri, Laia Paré, et al.
Nature Cancer
|
June 18, 2021
ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancer
Jiehui Deng, Aatish Thennavan, Igor Dolgalev, et al.
Page
of 45
Search research articles
Search
Showing results (411-420 of 447) with videos related to
Sort By:
Page
of 45
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2022
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer
Jonathan H Shepherd, Karla Ballman, Mei-Yin C Polley, et al.
Cancer Cell
|
February 5, 2010
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, et al.
Cancer Discovery
|
June 18, 2016
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer
Haikuo Zhang, Jun Qi, Jaime M Reyes, et al.
Nature Communications
|
September 3, 2021
Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer
Nathan F Schachter, Jessica R Adams, Patryk Skowron, et al.
NPJ Breast Cancer
|
May 13, 2021
FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036
Steven P Angus, Timothy J Stuhlmiller, Gaurav Mehta, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 5, 2025
Integration of Gene Expression and Digital Histology to Predict Treatment-Specific Responses in Breast Cancer
Frederick M Howard, James Dolezal, Hanna Hieromnimon, et al.
Cell
|
August 12, 2014
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
Katherine A Hoadley, Christina Yau, Denise M Wolf, et al.
Breast Cancer Research and Treatment
|
December 27, 2011
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
Laura J Esserman, Donald A Berry, Maggie C U Cheang, et al.
The Lancet. Oncology
|
November 5, 2020
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation
Aleix Prat, Valentina Guarneri, Laia Paré, et al.
Nature Cancer
|
June 18, 2021
ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancer
Jiehui Deng, Aatish Thennavan, Igor Dolgalev, et al.
Page
of 45